Skip to Main Content
Back to News

Insider Sale: Director at $PNC Sells 71 Shares

Automated

Linda R Medler, a director at $PNC, sold 71 shares of the company on 08-27-2025 for an estimated $14,594. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $PNC stock.

$PNC Insider Trading Activity

PNC Insider Trades

$PNC insiders have traded $PNC stock on the open market 23 times in the past 6 months. Of those trades, 2 have been purchases and 21 have been sales.

Here’s a breakdown of recent trading of $PNC stock by insiders over the last 6 months:

  • WILLIAM S DEMCHAK (CEO) has made 0 purchases and 18 sales selling 18,630 shares for an estimated $3,161,324.
  • E WILLIAM III PARSLEY (Executive Vice President) sold 7,665 shares for an estimated $1,349,040
  • KIERAN JOHN FALLON (Executive Vice President) sold 1,492 shares for an estimated $260,443
  • MARTIN PFINSGRAFF purchased 1,000 shares for an estimated $158,220
  • LINDA R MEDLER sold 71 shares for an estimated $14,594
  • MARK WIEDMAN (President) purchased 20 shares for an estimated $3,568

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PNC Hedge Fund Activity

We have seen 813 institutional investors add shares of $PNC stock to their portfolio, and 867 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$PNC Congressional Stock Trading

Members of Congress have traded $PNC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $PNC stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$PNC Analyst Ratings

Wall Street analysts have issued reports on $PNC in the last several months. We have seen 8 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Oppenheimer issued a "Outperform" rating on 07/30/2025
  • Citigroup issued a "Buy" rating on 07/17/2025
  • Morgan Stanley issued a "Underweight" rating on 07/17/2025
  • B of A Securities issued a "Buy" rating on 07/17/2025
  • RBC Capital issued a "Outperform" rating on 04/16/2025
  • Barclays issued a "Overweight" rating on 04/16/2025
  • JP Morgan issued a "Overweight" rating on 04/03/2025

To track analyst ratings and price targets for $PNC, check out Quiver Quantitative's $PNC forecast page.

$PNC Price Targets

Multiple analysts have issued price targets for $PNC recently. We have seen 14 analysts offer price targets for $PNC in the last 6 months, with a median target of $207.0.

Here are some recent targets:

  • Chris Kotowski from Oppenheimer set a target price of $238.0 on 07/30/2025
  • Keith Horowitz from Citigroup set a target price of $217.0 on 07/17/2025
  • Ebrahim Poonawala from B of A Securities set a target price of $226.0 on 07/17/2025
  • Betsy Graseck from Morgan Stanley set a target price of $186.0 on 07/17/2025
  • John McDonald from Truist Securities set a target price of $198.0 on 07/09/2025
  • David Konrad from Keefe, Bruyette & Woods set a target price of $212.0 on 07/09/2025
  • Daniel Tamayo from Raymond James set a target price of $220.0 on 07/08/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles